EKO SENSORA: Detecting Clinically Significant Murmurs

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope.

• Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography

Locations
United States
Michigan
Corewell Health Lakeland
RECRUITING
Saint Joseph
Contact Information
Primary
Monique Luna, MS
monique.allen@corewellhealth.org
2699838679
Time Frame
Start Date: 2023-10-26
Estimated Completion Date: 2025-07-26
Participants
Target number of participants: 300
Treatments
Other: Eko Device
Patients with cardiac risk factors
Related Therapeutic Areas
Sponsors
Leads: Spectrum Health - Lakeland

This content was sourced from clinicaltrials.gov